Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: PA2RE
Phospholipase A2 Receptor Enzyme-Linked Immunosorbent Assay, Serum
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Distinguishing primary from secondary membranous nephropathy
Monitoring patients with membranous nephropathy, over time, for trends in anti-PLA2R antibody levels
Highlights
Anti-phospholipase A2 Receptor (PLA2R) antibodies are highly specific for the diagnosis of primary membranous nephropathy.
As many as 70% to 75% of patients with primary membranous nephropathy are positive for anti-PLA2R.
A titer increase, decrease, or disappearance generally precedes a change in clinical status.
Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| PA2RI | Phospholipase A2 Receptor IFA, S | Yes | No |
Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
ELISA (PA2RE) testing is always performed initially. IFA testing (PA2RI) is performed based on the ELISA results. If ELISA results are greater than or equal 2 or less than or equal to 20 the IFA testing will reflex on.
Method Name A short description of the method used to perform the test
Enzyme-Linked Immunosorbent Assay (ELISA)
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
Phospholipase A2 Receptor ELISA, S
Aliases Lists additional common names for a test, as an aid in searching
Anti-PLA2R
PLA2R
PLA2R